Corporate Development Strategies to Raise Money for Nasal Drug Companies
Time: 9:40 am
day: Pre-Conference Workshop Day
Details:
The value of effectively conveying value and reduce perceived risk for potential investors is important. Why is raising capital for nasal drug companies so tough? How do you convey the unique value of a niche market like nasal drug delivery to investors who may not see the ROI? And with high R&D costs and complex regulatory hurdles, can investors be convinced of a long-term payoff?
This workshop will cover:
- Frameworks around securing money for startup and the different routes that are available
- Deciding when, how much, and from who?
- Case-study led insights to secure funding and futureproof successful entry to market
